The two grants totaling were awarded to ExonHit by the US Secretary of Health and Human Services to support its Alzheimer’s disease and oncology research and development projects.
ExonHit Therapeutics executive vice president Matthew Pando said that these awards also further highlight the ability of their Genome-Wide SpliceArray discovery platform to generate both innovative diagnostic and therapeutic products.
"These grants will contribute to support the ongoing development of two programs targeting areas of high medical need," Pando said.